Sign in

CIK 0001326190

  • Non-accelerated filer
  • Smaller reporting company

Altimmune, Inc.

Sign in to watch
Ticker
ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
202726770
Phone
+1 862-457-1450
Business address
350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
Former names
PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
  1. 4 Shares withheld for taxes President and CEO gave up 18,157 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Business Officer gave up 2,485 shares (to pay taxes)
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market sale Director sold 16,011 shares at an average $6.90 ($110,547)
  13. 4 Grant or award Acting Chief Financial Officer acquired 1,259 shares (grant or award)
  14. 4 Grant or award Chief Scientific Officer acquired 650 shares (grant or award)
  15. 4 Grant or award Chief Business Officer acquired 917 shares (grant or award)
  16. 4 Grant or award Chief Medical Officer acquired 1,486 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Shares withheld for taxes Chief Scientific Officer gave up 4,131 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Medical Officer gave up 4,133 shares (to pay taxes)
  20. 4 Shares withheld for taxes President and CEO gave up 15,689 shares (to pay taxes)

Page 5 of 34 · 674 filings